What is RxEDO?
RxEDO operates as a Prescription Benefit Partner, offering comprehensive prescription benefit management services. The company distinguishes itself through a commitment to integrity and transparency, employing a full disclosure business model that educates clients on current PBM practices and revenue streams. By aligning its services with client objectives, RxEDO caters to health plans, employers, and members, aiming to optimize prescription benefit effectiveness while prioritizing client interests. The company's focus on a transparent PBM model positions it as a unique player in the healthcare benefits sector.
How much funding has RxEDO raised?
RxEDO has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in RxEDO
PPP
Public-Private Partnership
What's next for RxEDO?
The substantial late-stage funding context suggests RxEDO is poised for significant scaling and market penetration. This capital injection will likely fuel strategic initiatives, including potential expansion of service offerings, enhancement of technological infrastructure, and broader market outreach. The company's emphasis on transparency and client advocacy in the PBM space positions it for continued growth and influence within the healthcare ecosystem.
See full RxEDO company page
